Medicare Enrolled
Dr. Rahul Ravilla, M.D
Hematology & Oncology · Albany, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ravilla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ravilla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ravilla
Dr. Rahul Ravilla is a hematology & oncology specialist in Albany, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Ravilla performed 76,846 Medicare services across 3,418 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ravilla received a total of $279,325 from 20 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ravilla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 9% volume in NY
$279,325 industry payments
Medicare Practice Summary
Medicare Utilization ↗76,846
Medicare services
Top 9% in NY for hematology & oncology
3,418
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,489 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 19,400 | $43 | $124 |
| Nivolumab injection (Opdivo) | 15,641 | $24 | $70 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
9,000 | $0 | $6 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
8,200 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,500 | $19 | $58 |
| Paclitaxel chemotherapy injection | 4,398 | $0 | $1 |
| Injection, docetaxel, 1 mg | 3,687 | $1 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,021 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 980 | $0 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
951 | $10 | $60 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
939 | $8 | $34 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
858 | $8 | $18 |
| Anti-nausea injection (Aloxi/palonosetron) | 850 | $1 | $114 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
588 | $95 | $217 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
441 | $7 | $27 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 397 | $3 | $373 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
357 | $99 | $622 |
| PSA test (prostate cancer screening) | 355 | $18 | $88 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
325 | $12 | $95 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
314 | $2 | $300 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
293 | $16 | $76 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 288 | $133 | $3,675 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
276 | $89 | $1,444 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
195 | $22 | $138 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
175 | $66 | $144 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
147 | $9 | $61 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
145 | $25 | $143 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
135 | $135 | $275 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
135 | $489 | $1,380 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
132 | $1 | $6 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
111 | $3 | $15 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
110 | $6 | $431 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
95 | $49 | $303 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $11 | $84 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
89 | $44 | $774 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
89 | $174 | $1,006 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
89 | $19 | $93 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
88 | $2 | $19 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
79 | $25 | $128 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
77 | $1,213 | $4,981 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
77 | $1 | $7 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 63 | $414 | $638 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
55 | $25 | $226 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
44 | $6 | $29 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
44 | $46 | $276 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $59 | $152 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
43 | $21 | $141 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $97 | $288 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
39 | $1 | $9 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $9 | $66 |
| New patient office visit, complex (60-74 min) | 35 | $163 | $419 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
34 | $1 | $19 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
29 | $34 | $647 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
28 | $75 | $528 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
27 | $13 | $56 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
27 | $69 | $156 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $91 | $225 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
21 | $4 | $20 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
21 | $6 | $32 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
21 | $15 | $82 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $38 | $100 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
16 | $13 | $76 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
14 | $15 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
91.1% medium
7.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$279,325
Total received (2018-2024)
Avg $39,904/year across 7 years
Top 3% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$260,040 (93.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,746 (6.4%)
Scientific / Research
Research funding and grants
$1,000 (0.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$539 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$91,857
2023
$83,421
2022
$48,823
2021
$41,863
2020
$11,822
2019
$81
2018
$1,458
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Exelixis Inc.
$37,948
Janssen Biotech, Inc.
$23,738
E.R. Squibb & Sons, L.L.C.
$16,379
Astellas Pharma US Inc
$7,942
Merck Sharp & Dohme LLC
$5,850
Top 3 companies account for 85.0% of 2024 payments
All-time payments by company (2018-2024) ›
Exelixis Inc.
$91,600
E.R. Squibb & Sons, L.L.C.
$85,919
Janssen Biotech, Inc.
$41,456
Merck Sharp & Dohme LLC
$17,070
Seagen Inc.
$16,319
Astellas Pharma US Inc
$13,974
Bayer HealthCare Pharmaceuticals Inc.
$3,631
AstraZeneca Pharmaceuticals LP
$2,740
Progenics Pharmaceuticals, Inc.
$1,980
Astellas Pharma Global Development
$1,743
PFIZER INC.
$1,000
Merck Sharp & Dohme Corporation
$1,000
Celgene Corporation
$300
Eisai Inc.
$124
Gilead Sciences, Inc.
$122
Amgen Inc.
$116
Genentech USA, Inc.
$81
Puma Biotechnology, Inc.
$76
Lilly USA, LLC
$54
Novo Nordisk Inc
$20
Top 3 companies account for 78.4% of all-time payments
Associated products mentioned in payments ›
CABOMETYX · CYRAMZA · Cabometyx · ERLEADA · INLYTA · KEYTRUDA · Kadcyla · LYNPARZA · Lenvima · Nerlynx · Nubeqa · OPDIVO · PADCEV · Padcev · Repatha · Tresiba · WELIREG · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for hematology & oncology in NY.
Geographic Context
Hematology & oncology specialists within 10 mi
37
Per 100K population
11.7
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ravilla is a mixed practice specialist, with above-average Medicare volume (top 9% in NY), with speaking/promotional industry engagement in the top 3% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ravilla experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Ravilla performed 19,400 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ravilla receive payments from pharmaceutical companies?
Yes. Dr. Ravilla received a total of $279,325 from 20 companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ravilla's costs compare to other hematology & oncology specialists in Albany?
Dr. Ravilla's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ravilla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Albany
Browse hematology & oncology specialists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology